Dehydroepiandrosterone Sulfate
"Dehydroepiandrosterone Sulfate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The circulating form of a major C19 steroid produced primarily by the ADRENAL CORTEX. DHEA sulfate serves as a precursor for TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE.
Descriptor ID |
D019314
|
MeSH Number(s) |
D04.210.500.054.079.429.625.300 D04.210.500.578.502.400.300 D06.472.040.502.400.300 D06.472.334.851.968.952.300
|
Concept/Terms |
Dehydroepiandrosterone Sulfate- Dehydroepiandrosterone Sulfate
- Sulfate, Dehydroepiandrosterone
- Prasterone Sulfate
- Sulfate, Prasterone
- DHA Sulfate
- Sulfate, DHA
- Dehydroisoandrosterone Sulfate
- Sulfate, Dehydroisoandrosterone
- DHEA Sulfate
- Sulfate, DHEA
|
Below are MeSH descriptors whose meaning is more general than "Dehydroepiandrosterone Sulfate".
Below are MeSH descriptors whose meaning is more specific than "Dehydroepiandrosterone Sulfate".
This graph shows the total number of publications written about "Dehydroepiandrosterone Sulfate" by people in this website by year, and whether "Dehydroepiandrosterone Sulfate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2010 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dehydroepiandrosterone Sulfate" by people in Profiles.
-
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol. 2013 Sep; 14(10):1009-19.
-
Organic anion transporter 6 (Slc22a20) specificity and Sertoli cell-specific expression provide new insight on potential endogenous roles. J Pharmacol Exp Ther. 2010 Sep 01; 334(3):927-35.
-
Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin. Anticancer Res. 2001 Nov-Dec; 21(6A):4051-4.
-
Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer. Cancer Epidemiol Biomarkers Prev. 2000 May; 9(5):517-21.
-
Serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate and the risk of developing gastric cancer. Cancer Epidemiol Biomarkers Prev. 1993 Jan-Feb; 2(1):33-5.
-
Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer. Cancer Res. 1992 Jan 01; 52(1):1-4.
-
Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause. Gynecol Oncol. 1991 Jan; 40(1):42-5.
-
Sex steroid hormones are altered in essential hypertension. J Hypertens. 1989 Mar; 7(3):181-7.
-
Time-related changes in the plasma concentrations of prolactin, gonadotropins, sex hormone-binding globulin, and certain steroid hormones in female runners after a long-distance race. Fertil Steril. 1986 Dec; 46(6):1067-70.